PRE-Operative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO)open access
- Authors
- Kim, Eun Kyoung; Choi, Hong-Mi; Choi, Eui-Young; Lee, Hye Sun; Park, Goeun; Han, Dong Woo; Lee, Sang-Eun; Park, Chan Seok; Hwang, Ji-won; Choi, Jae Hyuk; Kim, Mi-Na; Kim, Hyung-Kwan; Kim, Dae-Hee; Shin, Sung-Hee; Sohn, Il Suk; Shin, Mi-Seung; Na, Jin Oh; Cho, Iksung; Lee, Sun Hwa; Park, Yong Hyun; Park, Tae-Ho; Kim, Kye Hun; Cho, Goo-Young; Jung, Hae Ok; Park, Dae-Gyun; Hong, Ji Yeon; Kang, Duk-Hyun
- Issue Date
- 14-9월-2022
- Publisher
- BMC
- Keywords
- Echocardiography; Noncardiac surgery; Trial design
- Citation
- TRIALS, v.23, no.1
- Indexed
- SCIE
SCOPUS
- Journal Title
- TRIALS
- Volume
- 23
- Number
- 1
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/145752
- DOI
- 10.1186/s13063-022-06701-2
- ISSN
- 1745-6215
- Abstract
- Background: Cardiac evaluation using transthoracic echocardiography before noncardiac surgery is common in real-world practice. However, evidence supporting preoperative echocardiography is lacking. This study aims to evaluate the additional benefit of preoperative echocardiography in predicting postoperative cardiovascular events (CVE) in noncardiac surgery. Methods: This study is designed as a multicenter, prospective study to assess the utility of preoperative echocardiography in patients undergoing intermediate- or high-risk noncardiac surgery. This trial comprises two studies: (1) a randomized controlled trial (RCT) for patients undergoing intermediate-risk surgery with fewer than three clinical risk factors from the revised cardiac risk index (intermediate-risk group) and (2) a prospective cohort study for patients undergoing intermediate-risk surgery with three or more clinical risk factors, or who undergo high-risk surgery regardless of the number of clinical risk factors (high-risk group). We hypothesize that the use of preoperative echocardiography will reduce postoperative CVEs in patients undergoing intermediate- to high-risk surgery through discovery of and further intervention for unexpected cardiac abnormalities before elective surgery. A total of 2330 and 2184 patients will be enrolled in the two studies. The primary endpoint is a composite of all-cause death; aborted sudden cardiac arrest; type I acute myocardial infarction; clinically diagnosed unstable angina; stress-induced cardiomyopathy; lethal arrhythmia, such as sustained ventricular tachycardia or ventricular fibrillation; and/or newly diagnosed or acutely decompensated heart failure within 30 days after surgery. Discussion: This study will be the first large-scale prospective study examining the benefit of preoperative echocardiography in predicting postoperative CVE. The PREOP-ECHO trial will help doctors identify patients at risk of postoperative CVE using echocardiography and thereby reduce postoperative CVEs.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.